Sapiens(SPNS) - 2023 Q3 - Quarterly Report

Q3 2023 Financial Results Overview Sapiens reported strong Q3 2023 financial results, highlighted by significant growth, positive management commentary, and reaffirmed full-year guidance Summary Results for Third Quarter 2023 Sapiens reported strong financial results for Q3 2023, with significant year-over-year growth in both GAAP and Non-GAAP metrics. Revenue increased by approximately 10%, gross profit by over 10%, and operating income saw substantial growth, leading to improved margins and diluted EPS Metric (USD in millions, except per share data) | Metric (USD in millions, except per share data) | Q3 2023 (GAAP) | Q3 2022 (GAAP) | % Change (GAAP) | Q3 2023 (Non-GAAP) | Q3 2022 (Non-GAAP) | % Change (Non-GAAP) | | :--------------------------------------------- | :------------- | :------------- | :-------------- | :----------------- | :----------------- | :------------------ | | Revenue | $130.7 | $119.0 | 9.8% | $130.8 | $119.0 | 9.9% | | Gross Profit | $56.0 | $50.3 | 11.3% | $59.3 | $53.5 | 10.7% | | Gross Margin | 42.8% | 42.2% | 60 bps | 45.3% | 45.0% | 30 bps | | Operating Income | $20.3 | $16.6 | 22.4% | $24.1 | $20.9 | 15.1% | | Operating Margin | 15.5% | 13.9% | 160 bps | 18.4% | 17.6% | 80 bps | | Net Income (*) | $15.9 | $13.4 | 18.5% | $19.1 | $16.9 | 13.1% | | Diluted EPS | $0.28 | $0.24 | 16.7% | $0.34 | $0.30 | 13.3% | Management Commentary Sapiens' President and CEO, Roni Al-Dor, highlighted strong Q3 revenue growth, particularly in Europe and North America, driven by new customer wins and existing customer product expansion. The company also achieved further operating margin expansion, reinforcing its commitment to a growth strategy across diverse regions and product categories. Despite recent tragic events in Israel, global business operations continued smoothly - Strong revenue growth of 10% to $130.8 million, primarily driven by growth in European and North American regions[4] - Operating margin expanded to 18.4%, resulting in an operating profit of $24.1 million[6] - New logo win momentum and existing customer product expansion were healthy throughout the year[5] - Sapiens is strategically positioned for future growth and profitability through regional and product diversification[6] - Despite the war in Israel, global business operations continued smoothly due to a dedicated global employee base and support from customers, prospects, and partners[6] Full-Year 2023 Guidance Sapiens reiterated its full-year 2023 Non-GAAP revenue guidance and increased its Non-GAAP operating margin guidance, reflecting confidence in continued performance - Reiterated 2023 full-year Non-GAAP revenue guidance of $511 – $516 million[7] - Increased full-year 2023 Non-GAAP operating margin guidance from 18.0% – 18.2% to a range of 18.2% - 18.3%[7] Non-GAAP Financial Measures Explanation This section explains Sapiens' Non-GAAP financial measures, detailing their purpose, adjustments, and definitions for Adjusted EBITDA and Free Cash-Flow Purpose and Rationale Sapiens uses Non-GAAP financial measures to provide management and investors with useful information regarding financial and business trends, aiding in performance comparison, incentive compensation, budgeting, and evaluation against other software companies - Non-GAAP measures provide useful information to management and investors for understanding financial and business trends[10] - Management uses these measures for trend analyses, executive compensation, budgeting, and planning[10] - Non-GAAP measures offer an additional tool for investors to evaluate ongoing operating results and compare Sapiens' performance with other software companies[10] Definition of Non-GAAP Adjustments Non-GAAP financial measures are derived from GAAP measures by excluding specific items such as valuation adjustments on acquired deferred revenue, amortization of capitalized software and other intangible assets, stock-based compensation, acquisition-related costs, restructuring costs, and related tax adjustments. These exclusions aim to present a clearer view of core operational performance, though they do not replace GAAP results - Non-GAAP financial measures exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments[12] - Management does not consider these non-GAAP measures in isolation or as an alternative to GAAP financial measures, acknowledging their inherent limitations[13] - Investors are urged to review the reconciliation of non-GAAP to comparable GAAP financial measures[14] Adjusted EBITDA and Adjusted Free Cash-Flow Definitions Adjusted EBITDA is defined as net profit adjusted for various non-cash and non-operating items to provide a consistent view of operational performance. Adjusted Free Cash-Flow measures the cash surplus available for business expansion by adjusting operating cash flow for capitalized software development costs, capital expenditures, and certain acquisition-related payments - Adjusted EBITDA is defined as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses)[16] - Adjusted Free Cash-Flow is calculated by reconciling cash-flow from operating activities, reducing amounts for capitalization of software development costs and capital expenditures, and adding back cash payments for former acquisitions related to future performance targets and retention criteria[17] - Adjusted Free Cash-Flow is useful for evaluating the cash surplus available to fund business expansion[17] About Sapiens Sapiens is a global cloud-based SaaS provider for the insurance industry, with details on its profile and investor contacts Company Profile Sapiens International Corporation is a global provider of cloud-based SaaS software solutions for the insurance industry, with over 40 years of expertise. It serves over 600 customers in more than 30 countries, offering comprehensive solutions across property and casualty, workers' compensation, and life insurance markets - Sapiens is a leading global provider of cloud-based SaaS software solutions for the insurance industry[18] - The company has over 40 years of industry expertise and serves over 600 customers in more than 30 countries[18] - Sapiens offers comprehensive solutions for property and casualty, workers' compensation, and life insurance markets, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management[18] Investor and Media Contact Contact information for Sapiens' Chief Marketing Officer and Head of Investor Relations, Yaffa Cohen-Ifrah, and Investor Contacts Kimberly Rogers from Hayden IR, is provided for investor and media inquiries - Yaffa Cohen-Ifrah serves as Chief Marketing Officer and Head of Investor Relations for Sapiens[19] - Kimberly Rogers, Managing Director at Hayden IR, is also listed as an investor contact[19] Forward-Looking Statements This section outlines the nature of forward-looking statements within the press release, emphasizing that they are based on beliefs, assumptions, and expectations subject to various risks and uncertainties. It advises against undue reliance on these statements and refers readers to the company's Annual Report on Form 20-F for a detailed discussion of risk factors - Forward-looking statements are based on current beliefs, assumptions, and expectations, and are subject to certain risks and uncertainties[20] - Important factors could cause actual results to differ materially from those expressed or implied, including success in global expansion, M&A integration, lengthy development and sales cycles, customer retention, operational management, project complexities, privacy laws, intellectual property issues, cybersecurity risks, insurance industry risks, global operations risks (e.g., currency fluctuations, epidemics), and risks related to Israel operations[20] - Readers should not rely upon forward-looking statements as predictions of future events and are advised to review the 'Risk Factors' in the most recent Annual Report on Form 20-F[20] Detailed Financial Statements and Reconciliations This section presents detailed GAAP and Non-GAAP financial statements, including income, balance sheet, cash flow, EBITDA, and free cash flow reconciliations Condensed Consolidated Statement of Income (GAAP) The GAAP Condensed Consolidated Statement of Income shows Sapiens' financial performance for the three and nine months ended September 30, 2023, compared to the same periods in 2022. Key figures include revenue, gross profit, operating expenses, operating income, net income, and diluted earnings per share Condensed Consolidated Statement of Income (GAAP) - Key Figures (USD in thousands, except per share amounts) | Metric | Three months ended Sep 30, 2023 | Three months ended Sep 30, 2022 | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :--------------------------------------- | :------------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | | Revenue | 130,705 | 118,996 | 383,725 | 355,273 | | Gross profit | 55,952 | 50,275 | 163,645 | 149,858 | | Operating income | 20,265 | 16,552 | 58,779 | 50,010 | | Net income attributable to Sapiens' shareholders | 15,872 | 13,393 | 45,471 | 39,229 | | Diluted earnings per share | 0.28 | 0.24 | 0.82 | 0.71 | Reconciliation of GAAP to Non-GAAP Results This section provides a detailed reconciliation between GAAP and Non-GAAP financial measures for revenue, gross profit, operating income, and net income attributable to Sapiens' shareholders. It itemizes the specific adjustments made, such as valuation adjustments on acquired deferred revenue, amortization of capitalized software and other intangible assets, capitalization of software development, stock-based compensation, and acquisition-related costs Reconciliation of GAAP to Non-GAAP Results (USD in thousands, except per share amounts) | Metric | Three months ended Sep 30, 2023 (GAAP) | Three months ended Sep 30, 2023 (Non-GAAP) | Nine months ended Sep 30, 2023 (GAAP) | Nine months ended Sep 30, 2023 (Non-GAAP) | | :--------------------------------------- | :------------------------------------- | :--------------------------------------- | :------------------------------------ | :-------------------------------------- | | Revenue | 130,705 | 130,760 | 383,725 | 383,890 | | Gross profit | 55,952 | 59,260 | 163,645 | 173,615 | | Operating income | 20,265 | 24,058 | 58,779 | 69,989 | | Net income attributable to Sapiens' shareholders | 15,872 | 19,080 | 45,471 | 54,943 | - Key adjustments include valuation adjustment on acquired deferred revenue, amortization of capitalized software and other intangible assets, capitalization of software development, stock-based compensation, and acquisition-related costs[23] Adjusted EBITDA Calculation This section details the calculation of Adjusted EBITDA, starting from GAAP operating profit and adding back various non-GAAP adjustments and depreciation. It provides figures for both the three and nine months ended September 30, 2023 and 2022 Adjusted EBITDA (USD in thousands) | Metric | Three months ended Sep 30, 2023 | Three months ended Sep 30, 2022 | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :-------------------- | :------------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | | GAAP operating profit | 20,265 | 16,552 | 58,779 | 50,010 | | Non-GAAP adjustments | 3,793 | 4,350 | 11,210 | 12,408 | | Depreciation | 719 | 1,134 | 2,750 | 3,208 | | Adjusted EBITDA | 24,777 | 22,036 | 72,739 | 65,627 | Summary of NON-GAAP Financial Information This section provides a quarterly summary of key Non-GAAP financial metrics, including revenues, gross profit, operating income, Adjusted EBITDA, net income, and diluted EPS, showing trends over the past five quarters (Q3 2022 to Q3 2023) Summary of NON-GAAP Financial Information (USD in thousands, except per share amounts) | Metric | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | | :-------------------------- | :------ | :------ | :------ | :------ | :------ | | Revenues | 130,760 | 128,354 | 124,776 | 119,486 | 119,019 | | Gross profit | 59,260 | 57,992 | 56,363 | 53,774 | 53,546 | | Operating income | 24,058 | 23,417 | 22,514 | 21,058 | 20,902 | | Adjusted EBITDA | 24,777 | 24,393 | 23,569 | 22,092 | 22,036 | | Net income to Sapiens' shareholders | 19,080 | 18,610 | 17,253 | 18,022 | 16,871 | | Diluted earnings per share | 0.34 | 0.33 | 0.31 | 0.32 | 0.30 | Non-GAAP Revenues by Geographic Breakdown This sub-section presents Sapiens' Non-GAAP revenues broken down by geographic region (North America, Europe, Rest of the World) for the past five quarters, highlighting regional contributions to overall revenue Non-GAAP Revenues by Geographic Breakdown (USD in thousands) | Region | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | | :---------------- | :------ | :------ | :------ | :------ | :------ | | North America | 54,848 | 52,116 | 50,371 | 50,801 | 49,555 | | Europe | 64,662 | 62,960 | 64,572 | 56,910 | 56,887 | | Rest of the World | 11,250 | 13,278 | 9,833 | 11,775 | 12,577 | | Total | 130,760 | 128,354 | 124,776 | 119,486 | 119,019 | Non-GAAP Revenue Breakdown by Service Type This sub-section categorizes Non-GAAP revenue and gross profit by service type: 'Software products and re-occurring post-production services' and 'Pre-production implementation services,' along with their respective gross margins for the three and nine months ended September 30, 2023 and 2022 Non-GAAP Revenue Breakdown by Service Type (USD in thousands) | Revenue Type | Three months ended Sep 30, 2023 | Three months ended Sep 30, 2022 | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :-------------------------------------------------- | :------------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | | Software products and re-occurring post-production services | 87,356 | 74,950 | 251,757 | 222,539 | | Pre-production implementation services | 43,404 | 44,069 | 132,133 | 132,803 | | Total Revenues | 130,760 | 119,019 | 383,890 | 355,342 | Non-GAAP Gross Profit by Service Type (USD in thousands) | Gross Profit Type | Three months ended Sep 30, 2023 | Three months ended Sep 30, 2022 | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :-------------------------------------------------- | :------------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | | Software products and re-occurring post-production services | 46,053 | 41,369 | 133,339 | 119,414 | | Pre-production implementation services | 13,207 | 12,177 | 40,276 | 40,282 | | Total Gross profit | 59,260 | 53,546 | 173,615 | 159,696 | Non-GAAP Gross Margin by Service Type | Gross Margin Type | Three months ended Sep 30, 2023 | Three months ended Sep 30, 2022 | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :-------------------------------------------------- | :------------------------------ | :------------------------------ | :------------------------------ | :------------------------------ | | Software products and re-occurring post-production services | 52.7% | 55.2% | 53.0% | 53.7% | | Pre-production implementation services | 30.4% | 27.6% | 30.5% | 30.3% | | Gross Margin | 45.3% | 45.0% | 45.2% | 44.9% | Adjusted Free Cash-Flow This section presents the Adjusted Free Cash-Flow for the past five quarters, starting from cash flow from operating activities and adjusting for capitalized software development costs, capital expenditures, and acquisition-related payments Adjusted Free Cash-Flow (USD in thousands) | Metric | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | | :---------------------------------------- | :------ | :------ | :------ | :------ | :------ | | Cash-flow from operating activities | 3,988 | 14,603 | 22,188 | 14,430 | 4,405 | | Increase in capitalized software development costs | (1,638) | (1,679) | (1,658) | (1,238) | (1,492) | | Capital expenditures | (696) | (775) | (634) | (400) | (1,047) | | Free cash-flow | 1,654 | 12,149 | 19,896 | 12,792 | 1,866 | | Cash payments attributed to acquisition-related costs | - | - | 30 | 1,100 | - | | Adjusted free cash-flow | 1,654 | 12,149 | 19,926 | 13,892 | 1,866 | Condensed Consolidated Balance Sheet The Condensed Consolidated Balance Sheet provides a snapshot of Sapiens' financial position as of September 30, 2023, compared to December 31, 2022, detailing assets, liabilities, and equity Condensed Consolidated Balance Sheet - Key Figures (USD in thousands) | Metric | September 30, 2023 | December 31, 2022 | | :---------------------- | :----------------- | :---------------- | | ASSETS | | | | Total current assets | 290,387 | 285,307 | | Total long-term assets | 359,766 | 383,037 | | TOTAL ASSETS | 650,153 | 668,344 | | LIABILITIES AND EQUITY | | | | Total current liabilities | 139,601 | 145,956 | | Total long-term liabilities | 90,833 | 119,534 | | EQUITY | 419,719 | 402,854 | | TOTAL LIABILITIES AND EQUITY | 650,153 | 668,344 | - Cash and cash equivalents decreased from $160,285 thousand at December 31, 2022, to $97,061 thousand at September 30, 2023[32] - Total assets decreased from $668,344 thousand to $650,153 thousand, while total equity increased from $402,854 thousand to $419,719 thousand[32] Consolidated Statement of Cash Flow The Consolidated Statement of Cash Flow outlines the cash generated and used by Sapiens across operating, investing, and financing activities for the nine months ended September 30, 2023, compared to the same period in 2022 Consolidated Statement of Cash Flow - Key Figures (USD in thousands) | Cash Flow Activity | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :---------------------------------- | :----------------------------- | :----------------------------- | | Net cash provided by operating activities | 40,779 | 29,350 | | Net cash used in investing activities | (62,636) | (10,762) | | Net cash used in financing activities | (43,232) | (58,375) | | Decrease in cash and cash equivalents | (63,224) | (43,327) | | Cash and cash equivalents at the end of period | 97,061 | 146,916 | - Net cash provided by operating activities increased significantly from $29,350 thousand in 2022 to $40,779 thousand in 2023[33] - Net cash used in investing activities substantially increased from $(10,762) thousand in 2022 to $(62,636) thousand in 2023, primarily due to a large investment in deposits[33] Debentures Covenants Compliance As of September 30, 2023, Sapiens was in compliance with all financial covenants under the indenture for its Series B Debentures, demonstrating strong financial health relative to its debt obligations - Sapiens was in compliance with all financial covenants for its Series B Debentures as of September 30, 2023[34] Debentures Covenants Compliance as of September 30, 2023 | Covenant | Target | Actual | | :--------- | :------------------------------------------------------------------ | :------------------------------------------------------------------ | | 1 | Shareholders' equity (excluding non-controlling interest): above $120 million | Shareholders' equity (excluding non-controlling interest): $417.2 million | | 2 | Ratio of net financial indebtedness to net capitalization: below 65% | Ratio of net financial indebtedness to net capitalization: (36.68)% | | 3 | Ratio of net financial indebtedness to EBITDA (accumulated for four last quarters): below 5.5 | Ratio of net financial indebtedness to EBITDA: (1.19) |